Detect: Detection and diagnosis
This guide details how to diagnose AF using an ECG.
Protect: Anticoagulants available for your patients
The properties of NOACs may make them preferable to VKA for most eligible and appropriate NVAF patients, for example those who would struggle to attend regular clinic visits or who already take several concomitant medications. Find out more through these case studies.
Perfect: Improving anticoagulation services
The following patient leaflet is available to support you in helping your patients to understand more about their condition, treatment options and beyond:
- Patient leaflet on helping prevent stroke caused by NVAF
Case studies – assessment of anticoagulation
These case studies highlight typical scenarios that may arise during assessment of anticoagulation.
To support you in assessing your patients’ suitability prior to initiating treatment with ELIQUIS, a Prescriber Checklist is available here.
For patients who are switching from warfarin to ELIQUIS, a Patient Information Leaflet is available here.
Click here to view ELIQUIS (apixaban) prescribing and adverse event reporting information.
Job code: 432UK1900440-01
Date of preparation: September 2019